May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated, announced successful completion of patient enrollment in the ...
Ablation Systems
This channel provides technology news on new ablation system advances in cardiac electrophysiology (EP) used to treat dysfunctional heart tissue that cause arrhythmias. Each cell in the myocardium generates its own electrical impulses to cause the heart to beat, but if some cells generate signals that are not in synch with other parts of the heart, it causes an arrhythmia, an abnormal heart beat. Ablation systems use heat (usually generated by radio frequency, RF, energy or a laser) or extreme cold to cause small burns. These lesions create scar tissue that block electrical signals causing the arrhythmia. These procedures are guided by EP electro mapping systems.
-
-
May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, celebrates the achievements of the highly skilled electrophysiology team at ...
-
May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science and technology of cardiac arrhythmia treatment, enrolled the first patients in its ...
-
April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to guide and enhance cardiac ablation therapy through the acquisition of low-noise ...
December 21, 2022 — Stereotaxis, a global leader in robotic technologies for the treatment of cardiac arrhythmias ...
December 21, 2022
December 14, 2022 — Field Medical, Inc. and CardioNXT, Inc. announce a strategic collaboration to provide the first-of ...
December 14, 2022
November 10, 2022 — Biosense Webster, Inc., the global leader in cardiac arrhythmia treatment and part of Johnson & ...
November 10, 2022
November 10, 2022 — A national study led by UBC researchers at the Centre for Cardiovascular Innovation is shedding ...
November 10, 2022
October 24, 2022 — Acutus Medical, Inc, an arrhythmia management company focused on improving the way cardiac ...
October 24, 2022
October 14, 2022 — Biosense Webster, Inc., part of Johnson & Johnson MedTech†, today announced the European launch of ...
October 14, 2022
June 7, 2022 — Stereotaxis, a global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...
June 07, 2022
May 24, 2022 — Attune Medical, a pioneering medical device company with a technology platform based on temperature ...
May 24, 2022
May 17, 2022 — Results from a new study show success of intended same day discharge (SDD) improves over time for ...
May 17, 2022
May 13, 2022 — Acutus Medical, an arrhythmia management company focused on improving the way cardiac arrhythmias are ...
May 13, 2022
May 4, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias ...
May 04, 2022
May 2, 2022 – Johnson & Johnson MedTech have announced that Biosense Webster, Inc., a worldwide leader in the science ...
May 02, 2022
April 27, 2022 – CathVision, a medical technology company developing innovative electrophysiology solutions designed to ...
April 27, 2022
January 14, 2022 — Medtronic has entered into a definitive agreement to acquire Affera Inc., a Boston area-based ...
January 14, 2022
January 13, 2022 — Abbott received U.S. Food and Drug Administration (FDA) clearance for the EnSite X EP System with ...
January 13, 2022© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now